Cerenome CNSY
NASDAQ CNSY
$1.85 -0.02 (-1.08%)
As of: Oct 1, 2026 · 12:04 PM EDT

Cerenome (CNSY) Capital Expenditures (2010 - 2026)

Updated

Cerenome (CNSY) recorded Capital Expenditures of $499,000 in Q2 2026, compared with $7,000 a year earlier and down 39.0% from the prior quarter.

Analysis

Cerenome (CNSY) Capital Expenditures (2010 - 2026) Analysis & Trends

On a TTM basis, Cerenome's Capital Expenditures came in at $1.37 million as of Jun 30, 2026; for FY2025, it was $67,000, down 54.1% from FY2024.

  • Annual Capital Expenditures has declined for three straight years, with a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $146,000 in FY2024 (-8.8%), $160,000 in FY2023 (-68.6%), $509,000 in FY2022 (+253.5%) and $144,000 in FY2021 (+54.8%).
  • Quarterly Capital Expenditures has ranged from $3,000 in Q1 2025 to $818,000 in Q1 2026 over the past five years.
  • On a year-over-year basis, Capital Expenditures rose in three of the last six quarters, with growth averaging 8.0%.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 636.4% in Q2 2024, against a decline of 92.5% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $818,000 (Q1 2026), $30,000 (Q4 2025) and $27,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Cerenome 13.67 Mn -33.51 Mn - 499,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 499,000.00
Mar 31, 2026 818,000.00
Dec 31, 2025 30,000.00
Sep 30, 2025 27,000.00
Jun 30, 2025 7,000.00
Mar 31, 2025 3,000.00
Dec 31, 2024 11,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 81,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 42,000.00
Sep 30, 2023 10,000.00
Jun 30, 2023 11,000.00
Mar 31, 2023 97,000.00
Dec 31, 2022 128,000.00
Sep 30, 2022 33,000.00
Jun 30, 2022 138,000.00
Mar 31, 2022 210,000.00
Dec 31, 2021 10,000.00
Sep 30, 2021 54,000.00
API Access

Cerenome Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CNSY&period=max&api_key=YOUR_API_KEY